At AbbVie, we partner to achieve two important outcomes: to deliver innovative medicines and to make a remarkable impact on people’s lives.
We start with a highly integrated approach to developing and sustaining our partnerships. We work as one connected unit with a commitment to establishing collaborations across the development continuum that will ultimately benefit patients and fuel scientific progress.
Our goal is to create long-term mutually beneficial relationships. With a shared vision as our foundation, we align our collective capabilities in service of a joint mission to bring innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.
From start to finish, we ensure that everyone from working teams through senior leadership is aware of and invested in nurturing the assets we develop together. We manage for success—from early identification and mitigation of risks to shared accountability and reward for successful outcomes.
We focus on identifying and evaluating new opportunities that complement and enhance our existing internal innovation strategies. S&E works in close partnership with our R&D and commercial teams, BD&A and Ventures to thoughtfully address each opportunity.
We evaluate a variety of partnership structures to meet the needs of both parties. BD&A works closely with S&E, and our commercial and R&D organizations to evaluate new opportunities.
Highly successful partnerships result from an ongoing commitment to realize a shared vision. At AbbVie, we have a dedicated team that is involved in all aspects of the partnership from contracting through commercialization.
We strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation science and proven scientific leaders. Our expertise in drug development and commercialization can be a valuable resource to even the earliest stage companies
Our team is ready to meet with you to share our capabilities and discuss your business opportunities. We are always looking for innovation and new partnership opportunities that align with our focus areas. With offices in the Northern California, Chicago and Boston areas, as well as other locations around the world, we look forward to hearing from you.
Contact us to submit your idea.
Niels Emmerich, Vice President, Global Head Search & Evaluation
Murali Gopalakrishnan, Senior Director, Neuroscience
Liz Kowaluk, Senior Director, Specialty
Arpita Maiti, Senior Director, Immunology
Douglas Faunce, Executive Director, Eye Care
Chinmay Kanuga, Director, Allergan Aesthetics
Joachim Vogt, Director, Western Europe
Sergio Capancioni, Director, Western Europe
Wendy Tai, Director, Japan/Asia/Pacific
Jay Stamatis, Vice President, Head Business Development & Acquisitions
Rahul Jerath, Senior Director, Oncology
Tony Brazda, Senior Director, Allergan Aesthetics
Rachel Strick, Senior Director, Immunology
David Moss, Associate VP, Eye Care, Neuropsych, Migraine
John FitzGerald, Senior Director, Outlicensing, Specialty
Sridhar Mandapati, Head International Business Development
Anna Maroney, Vice President, Global Alliances
John Larson, Senior Director Global Alliance Leader, Oncology, Marketed Drugs
Jason Powell, Senior Director Global Alliance Leader, Oncology, Immunology
Jon Kern, Senior Director Global Alliance Leader, Allergan Aesthetics, Immunology
Shankar Subramanian, Senior Director Global Alliance Leader, Academic Collaborations
Melanie Patterson, Director Global Alliance Leader, Neuroscience, Oncology
Amanda McAllister, Director Global Alliance Leader, Specialty, Immunology, Oncology
Ching-Yi Wan, Associate Director Global Alliance Leader, Oncology
Rajiv Janjikhel, Executive Director Global Alliance Leader, Eye Care, Neuroscience
Cardine Nokwe, Director Global Alliance Leader, Specialty, Immunology
Margarita Chavez, Chicago / San Francisco area
John Gustofson, Boston / Cambridge area
Charles Kunsch, Ph.D., Boston / Cambridge area
Jasmina Marjanovic, Ph.D., Boston / Cambridge area
